| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Europe (Primary) | PRIMARYEUR | Univ | 6,241 | 21,107,412 | -0.11% | 3.05% | -1.59% | -0.95% | 4.64% | 20.51% |
| Healthcare | HEALTHCARE | Sector | 568 | 2,260,931 | 0.33% | 4.26% | -0.93% | -1.40% | 1.92% | 16.98% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 183 | 1,817,410 | 0.52% | 5.04% | 0.52% | 1.71% | 6.62% | 25.30% |
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 55 | 44,426 | 0.33% | 5.27% | -0.51% | 2.26% | 2.28% | 46.00% |
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 11 | 4,225 | -0.17% | 1.95% | -5.81% | -5.78% | -15.56% | 23.85% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 2,390 | 1.37% | 3.00% | 5.78% | 1.45% | -14.39% | 23.16% |
| Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 840 | 0.73% | 4.95% | 2.42% | 3.38% | 15.39% | 21.90% |
| Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,241 | 21,107,412 | -0.16% | 2.94% | -2.29% | -1.01% | 5.18% | 25.14% |
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 11 | 4,225 | -0.17% | 1.95% | -5.81% | -5.78% | -15.56% | 23.85% |
| Valneva SE | VLA:FRAVLA:FRA | Stock | 1 | 537 | -3.97% | -3.42% | -42.17% | -35.32% | -44.35% | -9.18% |
* Colors indicate performance relative to the benchmark.